Business Description
Scienture Holdings Inc
NAICS : 456110
SIC : 8999
ISIN : US80880X1046
Total Employee Number:
9Description
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 354.3 | |||||
Equity-to-Asset | 0.83 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -2.47 | |||||
Beneish M-Score | -1.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -88.4 | |||||
3-Year EBITDA Growth Rate | 8.4 | |||||
3-Year EPS without NRI Growth Rate | 28.5 | |||||
3-Year FCF Growth Rate | 37.4 | |||||
3-Year Book Growth Rate | 12.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 332.68 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.06 | |||||
9-Day RSI | 34.15 | |||||
14-Day RSI | 38.54 | |||||
3-1 Month Momentum % | 10.19 | |||||
6-1 Month Momentum % | -31.44 | |||||
12-1 Month Momentum % | -75.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.7 | |||||
Quick Ratio | 1.63 | |||||
Cash Ratio | 1.26 | |||||
Days Inventory | 871.5 | |||||
Days Sales Outstanding | 391.78 | |||||
Days Payable | 10189.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -301.9 | |||||
Shareholder Yield % | -148.16 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 80.71 | |||||
Operating Margin % | -3392.45 | |||||
Net Margin % | -8773.59 | |||||
EBITDA Margin % | -8270.65 | |||||
FCF Margin % | -2797.06 | |||||
OCF Margin % | -2797.06 | |||||
ROE % | -55.26 | |||||
ROA % | -43.56 | |||||
ROIC % | -16.53 | |||||
3-Year ROIIC % | -18.19 | |||||
ROC (Joel Greenblatt) % | -57218.13 | |||||
ROCE % | -44.66 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 15.02 | |||||
PB Ratio | 0.21 | |||||
EV-to-EBIT | -0.26 | |||||
EV-to-Forward-EBIT | -0.78 | |||||
EV-to-EBITDA | -0.27 | |||||
EV-to-Forward-EBITDA | 16.7 | |||||
EV-to-Revenue | 22.03 | |||||
EV-to-Forward-Revenue | 2.05 | |||||
EV-to-FCF | -0.79 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Median-PS-Value | 3.14 | |||||
Earnings Yield (Greenblatt) % | -384.62 | |||||
FCF Yield % | -95.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SCNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scienture Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.477 | ||
| EPS (TTM) ($) | -2.51 | ||
| Beta | 4.3019 | ||
| 3-Year Sharpe Ratio | -0.45 | ||
| 3-Year Sortino Ratio | -0.77 | ||
| Volatility % | 122.55 | ||
| 14-Day RSI | 38.54 | ||
| 14-Day ATR ($) | 0.030803 | ||
| 20-Day SMA ($) | 0.36533 | ||
| 12-1 Month Momentum % | -75.17 | ||
| 52-Week Range ($) | 0.2382 - 2.6 | ||
| Shares Outstanding (Mil) | 40.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Scienture Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Scienture Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 128 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 36 days | ||
| General meeting for 2026 | 2026-07-07 11:00 | In 1 day | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.41 (-0.65%) | ||
| Annual report for 2025 | 2026-03-30 | 0.42 (-8.61%) | ||
| Guidance call for 2025 | 2025-12-09 14:00 | 0.63 (+0.14%) | ||
| Annual Meeting of Stockholders | 2025-11-12 11:00 | 0.74 (+13.50%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 0.74 (+13.50%) | ||
| Second quarter earnings results for 2025 | 2025-08-12 | 2.12 (+0.47%) | ||
| First quarter earnings results for 2025 | 2025-05-12 | 0.92 (+2.22%) |
Show
Entries
Scienture Holdings Inc Frequently Asked Questions
What is Scienture Holdings Inc(SCNX)'s stock price today?
The current price of SCNX is $0.35. The 52 week high of SCNX is $2.60 and 52 week low is $0.24.
When is next earnings date of Scienture Holdings Inc(SCNX)?
The next earnings date of Scienture Holdings Inc(SCNX) is 2026-08-12 Est..
Does Scienture Holdings Inc(SCNX) pay dividends? If so, how much?
Scienture Holdings Inc(SCNX) does not pay dividend.
Guru Commentaries on NAS:SCNX
No articles.
Press Release
Articles on Scienture Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers